Cargando…

Extracorporeal Circulation Membrane Oxygenation Therapy for Acute Respiratory Diseases

Extracorporeal circulation membrane oxygenation provides pulmonary and/or cardiac support over a limited period of time for severe reversible cardio pulmonary diseases. It is an invasive technique with large risks associated but an improved survival rate of around 80%. It has strict selection criter...

Descripción completa

Detalles Bibliográficos
Autores principales: Kattan Said, Javier, González Morandé, Álvaro, Castillo Moya, Andrés
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121351/
http://dx.doi.org/10.1007/978-3-030-26961-6_73
_version_ 1783515183013953536
author Kattan Said, Javier
González Morandé, Álvaro
Castillo Moya, Andrés
author_facet Kattan Said, Javier
González Morandé, Álvaro
Castillo Moya, Andrés
author_sort Kattan Said, Javier
collection PubMed
description Extracorporeal circulation membrane oxygenation provides pulmonary and/or cardiac support over a limited period of time for severe reversible cardio pulmonary diseases. It is an invasive technique with large risks associated but an improved survival rate of around 80%. It has strict selection criteria for neonatal and pediatric patients. The main complications are hemorrhage, stroke, convulsions, cardiac failure, kidney failure, arterial hypertension, and hemolysis. Extracorporeal circulation membrane oxygenation must be implemented only in high-complexity neonatal and pediatric centers with trained personnel.
format Online
Article
Text
id pubmed-7121351
institution National Center for Biotechnology Information
language English
publishDate 2020
record_format MEDLINE/PubMed
spelling pubmed-71213512020-04-06 Extracorporeal Circulation Membrane Oxygenation Therapy for Acute Respiratory Diseases Kattan Said, Javier González Morandé, Álvaro Castillo Moya, Andrés Pediatric Respiratory Diseases Article Extracorporeal circulation membrane oxygenation provides pulmonary and/or cardiac support over a limited period of time for severe reversible cardio pulmonary diseases. It is an invasive technique with large risks associated but an improved survival rate of around 80%. It has strict selection criteria for neonatal and pediatric patients. The main complications are hemorrhage, stroke, convulsions, cardiac failure, kidney failure, arterial hypertension, and hemolysis. Extracorporeal circulation membrane oxygenation must be implemented only in high-complexity neonatal and pediatric centers with trained personnel. 2020-02-01 /pmc/articles/PMC7121351/ http://dx.doi.org/10.1007/978-3-030-26961-6_73 Text en © Springer Nature Switzerland AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Kattan Said, Javier
González Morandé, Álvaro
Castillo Moya, Andrés
Extracorporeal Circulation Membrane Oxygenation Therapy for Acute Respiratory Diseases
title Extracorporeal Circulation Membrane Oxygenation Therapy for Acute Respiratory Diseases
title_full Extracorporeal Circulation Membrane Oxygenation Therapy for Acute Respiratory Diseases
title_fullStr Extracorporeal Circulation Membrane Oxygenation Therapy for Acute Respiratory Diseases
title_full_unstemmed Extracorporeal Circulation Membrane Oxygenation Therapy for Acute Respiratory Diseases
title_short Extracorporeal Circulation Membrane Oxygenation Therapy for Acute Respiratory Diseases
title_sort extracorporeal circulation membrane oxygenation therapy for acute respiratory diseases
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121351/
http://dx.doi.org/10.1007/978-3-030-26961-6_73
work_keys_str_mv AT kattansaidjavier extracorporealcirculationmembraneoxygenationtherapyforacuterespiratorydiseases
AT gonzalezmorandealvaro extracorporealcirculationmembraneoxygenationtherapyforacuterespiratorydiseases
AT castillomoyaandres extracorporealcirculationmembraneoxygenationtherapyforacuterespiratorydiseases